This is a research study for people diagnosed with AML. The purpose of this study is to see if the treatment of a combination of two drugs (cytarabine liposome therapy) and adding a third drug (pomalidomide) in different doses is more effective.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Joshua Zeidner
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
21-2335
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
